Bisphosphonate-induced maxillo-mandibular osteo(chemo) necrosis;Bisphosphonates et ostéo(chimio)nécrose maxillo-mandibulaire

Revue de Stomatologie et de Chirurgie Maxillo-Faciale

Volumn 107, Issue 6, 2006, Pages 423-428

  Magremanne, M ^a   Vervaet, C ^a   Dufrasne, L ^a   Declercq, I ^b   Legrand, W ^b   Daelemans, Ph ^a  

^a ERASME HOSPITAL   (Belgium)

^b Centre Hospitalier Universitaire Ambroise Pare   (Belgium)

Author keywords

Bisphosphonates; Osteonecrosis

Indexed keywords

EID: 33845960254     PISSN: 00351768     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-1768(06)77081-4     Document Type: Article

References (18)

1. Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 2005;34:120-3.
2. Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg 2004;62:125-6.
3. Conte P, Guarneri V. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. Oncologist 2004;9:28-37.
4. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32:94-124.
5. st century? J Oral Maxillofac Surg 2005;63:682-9.
6. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34.
7. Robinson NA, Yeo JF. Bisphosphonates - a word of caution. Ann Acad Med Singapore 2004;33:48-9.
8. Marx R. Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7.
9. Carter G, Goss AN, Doecke C. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 2005;182:413-5.
10. Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O. Severe osteomyelitis of the jaws in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 2004;117:440-1.
11. st century: bisphosphonates-associated complications of the jaws. J Oral Maxillofac Surg 2004;62:1563-5.
12. Green JR. Bisphosphonates: preclinical review. Oncologist 2004;9(Suppl):3-13.
13. Coleman RE. Bisphosphonates: clinical experience. Oncologist 2004;9(Suppl):14-27.
14. Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castreded rats. Cancer Res 2002;62:6538-44.
15. Purcell PM, Boyd IW. Bisphosphonates and osteonecrosis of the jaws. Med J Aust 2005;182:417-8.
16. Migliatori CA. Biphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21:4253-4.
17. Agarwala S, Sule A, Pai BU, Joshi VR. Alendronate in the treatment of avascular necrosis of the hip. Rheumatology (Oxford) 2002;41:346-7.
18. Melo MD, Obeid G. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 2005;71:111-3.